awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39102244-208A25E3-37E5-4CBE-ADD2-1902249A325E
Q39102244-208A25E3-37E5-4CBE-ADD2-1902249A325E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39102244-208A25E3-37E5-4CBE-ADD2-1902249A325E
Update on the Use of Biologic Therapy in Ulcerative Colitis.
P2860
Q39102244-208A25E3-37E5-4CBE-ADD2-1902249A325E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39102244-208A25E3-37E5-4CBE-ADD2-1902249A325E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a9a8e55751a2a2a2c82c27c6933abf77a60dce5f
P2860
The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.